1-3 of 3
Annette May
Close
Sort by
Journal Articles

First Results of the Interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB) Multiple Myeloma (MM) Assessing TB-Questions, TB-Advice Adherence, TB-Satisfaction of Patients, Participants and Referring Physicians, Inclusion of Difficult-to-Treat-MM Pts in Clinical Trials (CT) and Patient Outcome

Ricarda Selder, Masa Pandurevic, Mandy-Deborah Möller, Johannes Waldschmidt, MD, Milena Pantic, Georg W. Herget, Karl Henne, Annette May, Martina Kleber, MD, Josefina Udi, MD, Gabriele Ihorst, Rainer Bredenkamp, Werner Vach, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2014) 124 (21): 2635.
https://doi.org/10.1182/blood.V124.21.2635.2635
Published: 2014
Journal Articles

Vorinostat (V) In Combination With Bortezomib (B), Doxorubicin (D) and Dexamethasone (D) (VBDD) In Patients With Refractory Or Relapsed Multiple Myeloma: An Interim Phase I/II Analysis

Martina Kleber, Dagmar Wider, Kristina Keller, Barbara Groß, Heike Reinhardt, Dorothee Jakobs, Mandy-Deborah Moeller, Manuela Burbeck, Milena Pantic, Annette May, Manfred Jung, PhD, Ralph Waesch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2013) 122 (21): 3202.
https://doi.org/10.1182/blood.V122.21.3202.3202
Published: 2013
Journal Articles

Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement

Lisa Billecke, PhD, Eva Maria Murga Penas, PhD, Annette May, PhD, Monika Engelhardt, Arnon Nagler, M.D., Merav Leiba, PhD, Nicolaus Kröger, PhD, Jozef Zustin, PhD, Andreas Marx, PhD, Jakob Matschke, Markus Tiemann, MD, Eray Gökkurt, Carsten Bokemeyer, MD, Georgia Schilling, PhD
Journal: Blood
Blood (2010) 116 (21): 4993.
https://doi.org/10.1182/blood.V116.21.4993.4993
Published: 2010